Genprex GNPX
NASDAQ GNPX
$2.63 +0.07 (+2.73%)
At close: Oct 2, 2026 · 4:00 PM EDT

Genprex (GNPX) Gross Profit (2024 - 2025)

Updated

Genprex's Gross Profit came in at -$483,065 for Q1 2025, compared with -$772,118 a year earlier.

Analysis

Genprex (GNPX) Gross Profit (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Genprex 1.33 Mn -40.81 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -483,065.00
Mar 31, 2024 -772,118.00
API Access

Genprex Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=GNPX&period=max&api_key=YOUR_API_KEY